Age Related Macular Degeneration Treatment in Austin Texas
Battling Macular Degeneration to Restore Eye Health
Age Related Macular Degeneration (AMD) is a degenerative disease of the retina that affects one’s ability to see in the center of their visual field. It typically affects people over 50 and significantly changes their quality of life by limiting the ability to see fine detail, read, drive or recognize facial features.
Risk factors associated with AMD include:
Results released by the Age-Related Eye Disease Study (AREDS), a major clinical trial sponsored by the National Eye Institute, indicates that high levels of antioxidants and zinc significantly reduce the risk of advanced AMD and its associated vision loss.
After the AREDS study was released, the medical community embraced the use of natural supplementation. This effectively bridged the gap between nutritional science and traditional medicine. However, the AREDS study looked at only antioxidants and zinc, confusing several consumers who used multivitamins and other nutritional supplements and were unsure of the effects on their health.
In response to this, Dr. Harper created a simple treatment solution called Sight Defense MV (Sight Defense + multivitamin). This product provides a high quality daily multivitamin, along with the AREDs recommended nutrients. It prevents the overlapping and most importantly the overdosing of nutrients that can happen when mixing and matching nutritional products. In addition, Dr Harper follows the latest science related to AMD, adding nutritional ingredients to her formulation as new clinical studies prove their safety and efficacy with AMD.
For example, In 2011, a specific form of omega-3 was upgraded in the Sight Defense-MV formulation when the clinical science revealed that this particular form of omega-3 doubled the absorption and efficacy of this critical nutrient. Commitment to quality ingredients and ground breaking research in the area of AMD have made this formulation meaningful for many patients experiencing or at risk for AMD.
Sight Defense MV is a specific formulation of antioxidants, nutrients, and minerals formulated by a physician to specifically support the nutritional needs of the eye and the rest of the body by combining an eye vitamin with a comprehensive multivitamin and healthy omega 3 fatty acids (EPA and DHA) – all of the patient’s supplement needs are met in taking one small packet twice daily.
There are two forms of AMD: dry and wet.
Dry AMD occurs when light-sensitive cells break down in the macula of your eye. This causes vision in the center of your eye to gradually blur, often resulting in a blurred spot in the center of your vision and loss of central vision.
A common symptom of dry AMD is slightly blurred vision resulting in difficulty recognizing faces. It tends to affect both eyes, although it can occur in only one eye as well. Those with this form of AMD tend to have difficulty recognizing faces. Another symptom is the appearance of drusen in the eye. Drusen are yellow deposits under the retina, often found in people over the age of 60. They can be detected during a comprehensive dilated eye exam.
Wet AMD occurs upon the growth of abnormal blood vessels behind the retina under the macula. These blood vessels tend to be fragile, leaking blood or fluid which then raises the macula. Damage from wet AMD is quick, with loss of central vision occurring quickly. Wet AMD is considered the more severe form of the two, but it can be detected by a symptom that causes straight lines to appear wavy. If this condition is present, it’s important to contact an eye care professional immediately for a comprehensive dilated eye exam.
Dry AMD has three stages, all of which may occur in one or both eyes:
1. Early AMD People with early AMD have either several small drusen (yellow deposits under the retina) or a few medium-sized drusen. At this stage, there are no symptoms and no vision loss.
2. Intermediate AMD People with intermediate AMD have either many medium-sized drusen or one or more large drusen. Some people see a blurred spot in the center of their vision. More light may be needed for reading and other tasks.
3. Advanced Dry AMD In addition to drusen, people with advanced dry AMD have a breakdown of light-sensitive cells and supporting tissue in the central retinal area. This breakdown can cause a blurred spot in the center of your vision. Over time, the blurred spot may get bigger and darker, taking more of your central vision. You may have difficulty reading or recognizing faces until they are very close to you.
If you have vision loss from dry AMD in one eye only, you may not notice any changes in your overall vision. With the other eye seeing clearly, you still can drive, read, and see fine details. You may notice changes in your vision only if AMD affects both eyes. If blurriness occurs in your vision, see an eye care professional for a comprehensive dilated eye exam.
Wet AMD is considered advanced AMD and does not have an early or intermediate stage. Both the wet form and the advanced dry form are considered advanced AMD. Vision loss occurs with either form. In most cases, only advanced AMD can cause vision loss.
AMD can occur during middle age, with the risk increasing as you age. Other risk factors include:
AMD is detected during a comprehensive eye exam that includes:
Your eye care professional also may do other tests to learn more about the structure and health of your eye.
During an eye exam, you may be asked to look at an Amsler grid. The pattern of the grid resembles a checkerboard. You will cover one eye and stare at a black dot in the center of the grid. While staring at the dot, you may notice that the straight lines in the pattern appear wavy. You may notice that some of the lines are missing. These may be signs of AMD.
If your eye care professional believes you need treatment for wet AMD, he or she may suggest a fluorescein angiogram. In this test, a special dye is injected into your arm. Pictures are taken as the dye passes through the blood vessels in your retina. The test allows your eye care professional to identify any leaking blood vessels and recommend treatment.
Dry AMD Once dry AMD reaches the advanced stage, no form of treatment can prevent vision loss. However, treatment can delay and possibly prevent intermediate AMD from progressing to the advanced stage, in which vision loss occurs. The National Eye Institute’s Age-Related Eye Disease Study (AREDS) found that taking a specific high-dose formulation of antioxidants and zinc significantly reduces the risk of advanced AMD and its associated vision loss. Slowing AMD’s progression from the intermediate stage to the advanced stage will save the vision of many people.
Wet AMD can be treated with laser surgery, photodynamic therapy, and injections into the eye. None of these treatments is a cure for wet AMD. Each treatment may slow the rate of vision decline or stop further vision loss, but the disease and loss of vision may progress despite treatment.
Laser surgery This procedure uses a laser to destroy the fragile, leaky blood vessels. A high energy beam of light is aimed directly onto the new blood vessels and destroys them, preventing further loss of vision. However, laser treatment also may destroy some surrounding healthy tissue and some vision. Only a small percentage of people with wet AMD can be treated with laser surgery. Laser surgery is more effective if the leaky blood vessels have developed away from the fovea, the central part of the macula. Laser surgery is performed in a doctor’s office or eye clinic. The risk of new blood vessels developing after laser treatment is high. Repeated treatments may be necessary. In some cases, vision loss may progress despite repeated treatments.
Photodynamic therapy A drug called verteporfin is injected into your arm. It travels throughout the body, including the new blood vessels in your eye. The drug tends to “stick” to the surface of new blood vessels. Next, a light is shined into your eye for about 90 seconds. The light activates the drug. The activated drug destroys the new blood vessels and leads to a slower rate of vision decline. Unlike laser surgery, this drug does not destroy surrounding healthy tissue. Because the drug is activated by light, you must avoid exposing your skin or eyes to direct sunlight or bright indoor light for five days after treatment. Photodynamic therapy is relatively painless. It takes about 20 minutes and can be performed in a doctor’s office. Photodynamic therapy slows the rate of vision loss. It does not stop vision loss or restore vision in eyes already damaged by advanced AMD. Treatment results often are temporary. It may require additional treatment.
No. Sight Defense MV contains not only an eye vitamin, but also a multivitamin plus healthy omega 3 fatty acids (EPA and DHA). When taking Sight Defense MV, no additional multivitamin is needed. In addition, taking Sight Defense MV prevents the overdosage of nutrients possible when adding a multivitamin to an eye vitamin.
No. The high levels of vitamins and minerals are difficult to achieve from diet alone. However, previous studies have suggested that people who have diets rich in green leafy vegetables have a lower risk of developing AMD.
If you have Dry AMD, you should have a comprehensive dilated eye exam at least once a year. Your eye care specialist will check for eye diseases and monitor your condition.
Because dry AMD can turn into wet AMD at any time, you should get an Amsler grid from your eye care professional. Use the grid every day to evaluate your vision for signs of wet AMD. This quick test works best for people who still have good central vision. Check each eye separately. Cover one eye and look at the grid. Then cover your other eye and look at the grid. If you detect any changes in the appearance of this grid or in your everyday vision while reading the newspaper or watching television, get a comprehensive dilated eye exam.
Wet AMD If you have wet AMD and your doctor advises treatment, do not wait. After laser surgery or photodynamic therapy, you will need frequent eye exams to detect any recurrence of leaking blood vessels. Studies show that people who smoke have a greater risk of recurrence than those who don’t. In addition, check your vision at home with the Amsler grid.
If you detect any changes, schedule an eye exam immediately.
If you have lost some sight from AMD, don’t be afraid to use your eyes for reading, watching TV, and other routine activities. Normal use of your eyes will not cause further damage to your vision. If you have lost some sight from AMD, ask your eye care professional about low vision services and devices that may help you make the most of your remaining vision. Ask for a referral to a specialist in low vision. Many community organizations and agencies offer information about low vision counseling, training, and other special services for people with visual impairments. A nearby school of medicine or optometry may provide low vision services.
Omega-3 fatty acids (EPA and DHA) are a critical building block of the retina. They help protect the retina against free radicals that can damage it. In addition, the Omega-3 fatty acids (EPA and DHA) may aid in the absorption of both Lutein/Zeaxanthin and Coenzyme Q- 10.
Lutein and its carotenoid relative Zeaxanthin have shown promise to help patients with AMD or those at risk of developing AMD. Lutein and Zeaxanthin are the only carotenoids found in both the macula and lens of the human eye and have dual functions in both tissues. They function as powerful antioxidants and act to filter high-energy blue light which can damage the retina.
The dry form is much more common. More than 85 percent of all people with intermediate and advanced AMD combined have the dry form.
However, if only advanced AMD is considered, about two-thirds of patients have the wet form. Because almost all vision loss comes from advanced AMD, the wet form leads to significantly more vision loss than the dry form.
Yes. All people who have the wet form had the dry form first. The dry form can advance and cause vision loss without turning into the wet form.
The dry form also can suddenly turn into the wet form, even during early stage AMD. There is no way to tell if or when the dry form will turn into the wet form.
Wet AMD can now be treated with a new drug that is injected into the eye (antiVEGF therapy). Abnormally high levels of a specific growth factor occur in eyes with Wet AMD and promote the growth of abnormal new blood vessels. This drug treatment blocks the effects of the growth factor. You will need multiple injections, usually given about six weeks apart. The eye is numbed before each injection. After the injection, you will remain in the doctor’s office for a while and your eye will be monitored. As with photodynamic therapy, the main benefit for patients treated with the drug is to slow vision loss from AMD.
Keeping your eyesight safe is essential. Call Ruthie Harper, MD today at (512) 710-1374 for more information about macular degeneration and how to protect your eyesight!
Ready to Book a Consultation?